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Abstract
Microglia, the only lifelong resident immune cells of the central nervous system (CNS), are highly 
specialized macrophages which have been recognized to play a crucial role in neurodegenerative 
diseases such as Alzheimer’s, Parkinson’s and Adrenoleukodystrophy (ALD). However, in 
contrast to other cell types of the human CNS, bona fide microglia have not yet been derived from 
cultured human pluripotent stem cells. Here we establish a robust and efficient protocol for the 
rapid production of microglia-like cells from human embryonic stem (ES) and induced pluripotent 
stem (iPS) cells that uses defined serum-free culture conditions. These in vitro pluripotent stem 
cell-derived microglia-like cells (termed pMGLs) faithfully recapitulate the expected ontogeny and 
characteristics of their in vivo counterparts and resemble primary fetal human and mouse 
microglia. We generated these cells from multiple disease-specific cell lines, and find that pMGLs 
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derived from MeCP2 mutant hES cells are smaller than their isogenic controls. We further 
describe a culture platform to study integration and live behavior of pMGLs in organotypic 3D-
cultures. This modular differentiation system allows the study of microglia in highly defined 
conditions, as they mature in response to developmentally relevant cues, and provides a framework 
to study the long-term interactions of microglia residing in a tissue-like environment.
INTRODUCTION
Microglia are the resident macrophages of the central nervous system (CNS) 1. Expanding 
on previous developmental studies 2,3, recent genetic lineage tracing in the mouse 
determined that microglia take up residence in the developing neural tube shortly before 
closure of the blood-brain barrier 4. They emigrate as erythromyeloid precursors or primitive 
macrophages from the yolk sac, before further hematopoiesis takes place in the periphery. In 
contrast to other adult tissue monocyte-derived macrophages, microglial identity is a 
combination of unique mesodermal ontogeny (primitive myelopoiesis) and lifelong 
residence in an immune-privileged neuro-glial environment. Their phenotype is shaped by 
the developmental stages of the nervous system as it transitions from neurogenesis and 
gliogenesis, to synaptogenesis and network maturation 5, to a largely post-mitotic aging 
tissue in absence of injury.
Microglia have emerged in recent years as primary modulators of both development and 
pathogenesis of the nervous system, urgently requiring study. However, unlike bone marrow 
and monocyte-derived macrophages, primary human microglia remain poorly characterized 
as they differ greatly from mature mouse microglia, are not easily accessible and current 
methods employed for isolation likely alter their defining characteristics6. In vitro 
approaches to model and study CNS disorders using human iPS and ES derived cultures are 
currently lacking this important component. Robust protocols have been developed to induce 
human ES or iPS cells to differentiate into the different neuroectodermal cell types of the 
CNS including neurons, astrocytes and oligodendrocytes 7,8. Protocols recapitulating 
classical hematopoiesis, followed by expansion of monocytes have shown that myeloid cells 
can be generated from mouse and human ES cells 9. However, generation of microglia-like 
cells matching the recently identified signatures of acutely isolated microglia 10,11, and 
following their non-monocytic yolk sac ontogeny 4, has not been reported from pluripotent 
human cells.
Here, we describe an efficient method to generate microglia-like cells from human ES and 
iPS cells representing a collection of control and disease subjects. Using recent insights into 
microglial differentiation 12, we show that microglia-like cells can be efficiently generated 
and enriched from multiple ES and iPS cell lines. Expression signatures of these pluripotent 
stem cell-derived microglia resemble those of purified human fetal microglia maintained in 
the same culture conditions and recapitulate the recently defined consensus signature of 
microglia compared to other macrophages 13,10,11. They perform the functions of 
professional phagocytes, are positive for microglial markers such as TMEM119, and react to 
canonical stimuli. Our results provide a system to study the maturation and steady-state 
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behavior of human microglia in a highly defined cellular environment, and their involvement 
in disease onset, propagation and resolution.
RESULTS
A basal medium for the maintenance of human and murine fetal microglia
Serum-based media have been the mainstay of microglial isolation techniques over the years 
but these undefined culture conditions may unpredictably alter their characteristics. Building 
on recent refinements of the work of Brewer and colleagues 14 we have developed a fully-
defined, serum-free Neuro-Glial Differentiation media (referred to as NGD), the component 
concentrations of which were adjusted to match those of human cerebrospinal fluid 
(Supplementary Table 1). Compared to the complexity of other published culture conditions, 
NGD constitutes a single defined serum-free medium allowing culture of multiple neural 
and glial cell types, as well as other cells of interest. Neural differentiation can be initiated in 
NGD by addition of a small molecule inhibitor of TGFβ signaling (dorsomorphin) 15. 
Neural progenitors can be expanded by addition of FGF2 to the NGD base and 
differentiation into neurons and glia can be subsequently triggered by FGF2 removal.
To selectively culture microglia, we used commercially available modified polystyrene 
(Primaria) plates that allow adherent maintenance of mouse neonatal microglia and human 
fetal microglia (mNMG and hFMG, respectively) while maintaining the possibility of 
enzymatic passaging (Supplementary Fig. 1a). In contrast, neuroglial derivatives from neural 
progenitors are poorly adherent, and thus selected against on this substrate (not shown). 
IL-34 and CSF1g, important for microglia differentiation and maintenance in vivo 16,17, 
were added to the medium. Both hFMGs and mNMGs died in the absence of any CSF1R 
agonist, with hFMGs adopting a more ramified morphology in the presence of high 
concentrations of IL-34 (Supplementary Fig 1a, b). Primary cells could be maintained in this 
medium for more than a month without passaging, suggesting this formulation may be 
generally useful for primary myeloid cultures.
Induction of primitive microglia from human pluripotent cells
Human ES or iPS cells were grown in hES medium on feeder layers of murine embryonic 
fibroblasts. Following enzymatic passaging, uniform cell clusters, free of single cells, were 
used for initial embryoid body seeding. These clusters were re-suspended directly in NGD 
(without stepwise adaptation) containing 10ng/mL CSF1 and IL-34 (microglial 
differentiation medium, MGdM) in Corning ultra-low adherence plates. After one week, we 
observed the formation of two types of structures: dense neuralized spheroids appearing 
alongside embryoid bodies forming cystic structures, bound by a single cell layer (Fig. 1a). 
When plated at these early stages on poly-D-lysine, the neuralized EBs flattened into typical 
rosette-forming neuroepithelium, while the small cystic EBs flattened into cell lawns 
reminiscent of endothelial cells 18 (Supplementary Fig. 1b). Island whorls could be seen 
giving rise to three-dimensional clusters of round cells at their borders, organizing 
themselves in ropes (Fig. 1b). Proliferation and growth of these structures after attachment is 
CSF1R-ligand dependent, as they arrested and devolved in absence of CSF1 and IL-34 (not 
shown).
Muffat et al. Page 3
Nat Med. Author manuscript; available in PMC 2017 March 26.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The cells at the island borders and in the three-dimensional ropes were positive for VE-
Cadherin, c-kit CD41 and CD235a (Fig. 1b,c), which have been identified in mouse as 
markers of early yolk sac myelogenesis before definitive hematopoiesis or the establishment 
of embryonic circulation (<E8.5) 19. This immuno-histochemical panel is consistent with 
these cells representing the in vitro counterparts of early haemogenic endothelia 20. Based 
on this pattern of marker expression in the cystic EBs, we refer to them hereafter as Yolk 
Sac-EBs (YS-EBs). Large domains of the YS-EBs were positive for the master myeloid 
transcription factor PU.1 (Fig. 1d), which is necessary for microglial differentiation and 
maintenance 21,22 and can induce macrophages from fibroblasts 23. Under phase-contrast 
microscopy, clusters of cells were seen to delaminate towards the lumen of the cysts (Fig. 
1e) as well as directly into the outer medium or on the plastic culture surface.
Fig. 2a summarizes the protocol and the timeline used to generate microglia-like cells from 
human ES and iPS cells. When harvested and plated separately on Primaria, semi-adherent 
cells appear vacuolated, round and motile, and stain positive for PU.1, as well as CD11b and 
IBA1 (AIF1) ((Fig. 2b,c, Supplementary Movie 1). These markers have been extensively 
used to label or define microglia in various systems 24. These cells can be further sorted by 
FACS and are homogeneously positive for IBA1, CD45 and CD11b (Fig 2d, e), with the 
majority of cells physically selected by the growth conditions positive for all markers. We 
went on to characterize these immature cells and their progeny, which we refer to as 
pluripotent stem cell-derived microglia-like cells (pMGLs). The immature pMGLs initially 
delaminating from YS-EBs are round yet already highly phagocytic, as observed by the 
uptake of fluorescent latex beads and the appearance of filopodia and membrane ruffles, 
allowing the capture of nearby corpuscles such as inert plastic beads (Fig. 2f, g and 
Supplementary Movies 1, 2). The cells are highly motile and will readily tax to and 
encapsulate foreign bodies such as fibers present in the well (Fig. 2f).
Initially, EdU incorporation was seen in 60% of nuclei from early pMGLs (2 weeks from 
onset of production). After 2 months in culture, EdU incorporation showed that less than 5% 
of pMGLs kept in MGdM were mitotic within a 24-hour period (Fig. 2h). Importantly, both 
primary fetal microglia and pMGLs could be maintained for several months in culture 
despite ultimately limited renewal potential, demonstrating their longevity.
To assess the reproducibility of the differentiation protocol, we induced microglia from 20 
different ES and iPS cell lines representing a panel of healthy and disease genotypes 
(Supplementary Table 2), and successfully generated pMGLs from all lines. Supplementary 
table 2 reports quantitative output at an early cutoff of 4 weeks, matching the cutoff for 
NPCs. The cumulative yields are significantly higher. For example, after 8 weeks of 
differentiation, hES-wibr1, iPS-wt1, iPS-wt4, iPS-ALD4 and iPS-ALD1 respectively 
generated 1×106, 1×106, 3×106, 2×106, and 8×106 microglia-like cells, from 2×106 
pluripotent stem cells at the onset. We conclude that the differentiation protocol is efficient 
and robust, though the genetic background of the pluripotent donor affects the kinetics and 
yield of the microglia-like cells.
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Phenotypic and functional characterization of pMGLs
In culture, monocyte-derived macrophages adopt either a “fried-egg” morphology, or an 
axial bipolar spread reflecting the macrophage polarization and activation status 25. In 
contrast, a typical characteristic of microglia is to become highly ramified in vivo. To assess 
the phenotypic characteristics of the cells, we cultured pMGLs in a maintenance medium 
(MGM) containing high concentrations of IL-34 (100ng/mL) and low concentration of CSF1 
(5ng/mL), in NGD base. As shown in Fig. 3a, b and Supplementary Movie 3 and 4, primary 
human FMGs and pMGLs derived from hES or hiPS cells adopted an identical morphology, 
characterized by multiple thin first-order branching terminated by actively motile membrane 
ruffles, around an immobile soma.
Microglia were missing from our study of isogenic MECP2 wild type and mutant human 
ES-derived neural cells 26, yet their involvement in Rett syndrome has become in recent year 
the focus of great interest 27, following controversial findings that transplanted wild-type 
phagocytes derived from bone marrow could rescue features of Rett syndrome 28. pMGLs 
have the potential to clarify some of the cell autonomous and non-cell autonomous aspects 
of Rett microglial biology. We derived pMGLs from isogenic male wild-type and MECP2 
mutant cells, and observed that mutant cells were significantly smaller than the wild-type 
cells (Fig. 3c).
Mature pMGLs stained positive for markers of murine and human microglia 10,11,29,30, with 
both TMEM119 and P2RY12 displaying a broad membrane and punctate vesicular 
expression pattern, consistently with their roles as part of the microglial sensome (Fig. 3e, f). 
The majority of pMGLs at this stage were positive for TMEM119, IBA1 and CD45 (Fig. 
3g).
We assessed cytokine and chemokine profiles released in the supernatant of pMGL cultures. 
Unstimulated pMGLs secreted detectable levels of various cytokines and chemokines, 
including IL-8, CXCL1 or CCL2 (Fig. 4a, b). Furthermore, the addition of IFN-γ and 
endotoxin (LPS) triggered the release of chemokine and cytokines above baseline (Fig. 4a–
d). In particular, CXCL10, MIP1a, IL-6 and TNFα were increased more than 2-fold within 
the dynamic range of this assay. We verified that this effect was detectable at the 
transcriptional level, with an increase in mRNA of IL-6 and TNFα (Fig. 4c, d).
These results indicate that monocultures of pMGLs can be a substrate to study the functional 
and morphological changes in microglia, derived from isogenic parental cells, or to screen 
for modulators of inflammation.
pMGLs resemble primary human microglia, and differ from peripheral macrophages
We used the molecular signature specific of microglia, which is distinct from other 
macrophages 11,29,31, to compare the transcriptome of pMGLs with bona fide primary 
human microglia. Isolated human fetal microglia and pMGLs were grown in the same 
maintenance medium for a week (MGM). This comparison is relevant since pMGLs are 
directly isolated from differentiating pluripotent stem cell cultures and grown in serum-free 
neuroglial-compatible conditions. We found that pMGLs display a signature strikingly 
resembling that of fetal human microglia kept in the same conditions. Supplementary Table 
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3 shows that the top GO categories coincide between both cell types. pMGLs differ in the 
enrichment of gene categories related to the establishment and modulation of the 
extracellular matrix (ECM, Suppl. Tables 4 and 5). The differentially expressed genes 
between primary cells and in vitro derived pMGLs did not include any of the canonical 
myeloid ontology terms, supporting their use as surrogate for human microglia. Several 
individual genes were highly expressed in primary human fetal microglia and pMGLs, 
consistent with their identity (Suppl. Fig. 2a). Among those genes were CD11b (ITGAM), 
ITGB2, CSF1R, CD45, IBA1, ADORA3 or LGMN. In addition, pMGLs highly expressed 
genes relevant to nervous system disorders such as APOE, CD33 and TREM2 
(Supplementary Fig. 2b). Likewise, HEXB, a causal gene for the lysosomal storage 
Sandhoff disease, was highly expressed in pMGLs, supporting the interest in microglial 
catabolism of GM2 ganglioside 32. Neural progenitors derived from the same pluripotent 
stem cells and further differentiated into complex cultures of neurons and glia (Diff. NPCs, 
see Fig. 6), express these genes to much lower levels (Fig. 5 and Supplementary Fig. 2), 
highlighting the lack of overlap between these mesodermal and neuro-ectodermal lineages, 
despite their side-by-side residence in the brain, in vivo.
To characterize pMGLs we used a consensus subset of genes that is highly expressed in 
microglia but poorly expressed in other macrophages, combining the most relevant genes of 
the microglial sensome 11, the unique TGFβ-dependent signature of microglia 29, and the 
microglial cassette found to be upregulated in TMEM119+ microglia during postnatal mouse 
development 10 (see Suppl. Table 8 for microglial genes compounded from Bennett et al. 
2016). These include genes coding for the transmembrane protein TMEM119, the proto-
oncogene MERTK, the phospholipid binding protein PROS1, the putative synaptic-tagging 
complement factor C1QA, the inhibitory receptor LAIR1, the GPCR GPR34, the 
ectonucleotidase ENTPD1, the purinergic sensors P2Y12/13, and the main TGFβ signaling 
partners TGFβ1 and TGFβR1. The expression of these markers appears to be positively 
correlated with maturation time in vivo, increasing in adult animals as compared to 
newborns 29. Conversely, their expression seems to be negatively correlated with time in 
culture, being highest in freshly isolated cells and lowest in maintained primary cells and 
transformed lines. Most of these genes are in fact expressed at higher levels in pMGLs than 
in primary human fetal microglia (Fig. 5A, supplementary Fig. 2), supporting their identity 
as in vitro generated microglia. Notably, these genes are expressed at low levels in cultured 
macrophage cell lines as well as in previously described mouse ES-derived microglia 33. 
Conversely, genes such SLPI, SAA1/2, PRG4, CFP, CD5l, CRIP1 are expected to be highly 
expressed in peripheral macrophages, and low in microglia 11: these genes are in the lower 
expression quartile of our dataset. Genes such as GPR56 and BIN1 are expressed in 
microglia and in other CNS cell types, but have not been described in peripheral 
macrophages. Supplementary Figure 2c shows their expression in pMGLs, fMG, as well as 
differentiated NPCs. We performed unbiased hierarchical clustering of our data against 
previously published sequencing for primary and induced macrophages. As expected, all 
myeloid cells cluster away from parental iPS cells and NPCs. Strikingly, we find that 
pMGLs and primary fetal microglia cluster together, separately from other macrophages 
(Suppl. Figure 3b).
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In the mouse, several microglia-specific genes appear to be upregulated in brain-resident 
microglia through early postnatal development 10. For example, SELPLG, CST3, TXNIP, 
P2RY13, OLFML3 are upregulated (respectively 16, 11, 9, 5 and 5-fold) between embryonic 
day 17 and postnatal day 60. In our cultures, we find that SELPLG, CST3 and TXNIP are 
already expressed at high levels in both FMGs and pMGLs, while OLFML3 and P2RY13 
are more than 4-fold higher in pMGLs compared to FMGs. We also note that pMGLs 
display high expression of both PU.1 and IRF8, but very low levels of MYB (Suppl. Fig 3a) 
consistent with microglia emerging from PU.1 and IRF8-dependent, but MYB-independent 
cells 34–37.
We further performed unbiased hierarchical clustering of our data against previously 
published data on primary human brain cells isolated by immuno-panning, including 
neurons, fetal and mature astrocytes, and adult microglia 31. We find that pMGLs form a 
cluster with both fetal and mature primary microglia, while iPS-derived neural cells cluster 
with primary neurons and glia, close to fetal astrocytes (Figure 5b).
The pMGL phenotype is affected by co-cultivation with neurons
We observed that exposure to undifferentiated neural progenitor conditioned medium 
maintains the rounded phenotype of immature microglia and promotes their proliferation. 
We investigated whether maturation of pMGLs in the presence of human pluripotent stem 
cell-derived mature neural cells would further refine their molecular signature (Fig. 6a, top 
panel). Principal component analysis of the transcriptome revealed that primary fetal 
microglia and pMGLs cluster tightly together along PC1, and segregate away from 
differentiated neural progenitors cultured in the same conditions (Fig. 6b). The difference 
between NPCs and pMGLs along PC1 may reflect the main myeloid vs neural identity, 
accounting for ~77% of sample variance, while the variation along PC2 (~12% of sample 
variance) may be refined by tissue residency, ECM and cell/cell interactions. To directly test 
this notion, we grew pMGLs in conditioned medium from differentiating neural cultures 
(defined before conditioning, with no other variation in recombinant growth factor 
concentrations). Fig. 6b shows that, after 2 weeks, the pMGLs partially shifted their 
signature towards that of primary microglia along the PC2 axis.
To test whether physical embedding and maturation of pMGLs in a 3D organotypic 
neuroglial environment would accentuate their branching patterns and allow us to observe 
their surveying behavior, we transduced immature pMGLs with a GFP lentivirus and re-
aggregated the GFP-positive pMGLs with pre-differentiated neural cultures, at a stage where 
neurons have already become post-mitotic and gliogenesis is ongoing (>4weeks). The re-
aggregates were either kept in spinning suspension cultures to maximize viability, or as 
200μm-thick cultures in transwells, so as to avoid triggering pMGL activation from hypoxia 
of the surrounding tissue and allow live observation. In this context, an entire spheroid or 
cellular stack is self-assembling, laying down its own extracellular matrix without need for 
additional scaffold (Fig. 6a, lower panel). The neural progenitors progressively differentiated 
into neurons and macro-glia (astrocytes, oligodendrocytes), and would be devoid of any 
microglia without the exogenous addition of pMGLs. GFP-labeled pMGLs, which had 
adopted rounded to first-order ramified morphologies when cultured on plastic, integrated 
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into the three-dimensional cultures, tiled the volume (Fig. 6c), and projected highly 
branched ramifications (Fig. 6d). The 3D culture matrix is a cortex-like mesh of MAP2 
positive neurites and GFAP positive astrocytic branches (Fig. 6e). Live Imaging of the GFP 
positive pMGL branches in situ showed rapid extension and retraction of filopodial arbor 
termini (Fig. 6f, g and Supplementary Movies 6, 7). These results suggest that pMGLs can 
integrate into organotypic neural cultures, and mature into what is currently defined as 
resting yet dynamically motile microglia. We note that this magnitude of extension and 
retraction is not observed in 2D cultures on Primaria or glass coverslips, where non-
amoeboid pMGLs only display terminal ruffle movement, on a much smaller scale.
Embedded pMGLs rapidly respond to cellular damage
One of the characteristics of microglia in vivo is their ability to survey the parenchyma from 
their static tiling positions, yet revert to an amoeboid and actively migrating state in response 
to injury. Migration towards a site of cellular damage is driven by purinergic receptors such 
as P2RY12/13, in response to ATP/ADP release from dying cells. We took advantage of our 
3D culture system to model such localized damage and observe microglial behavior in real-
time. Figure 6h and Supplementary Movies 8, 9 display the time-lapse reaction of embedded 
GFP+ microglia to a focal laser injury (yellow arrowhead at 5′). Microglia reacted within 
minutes by extending a single long process towards the injury center, making contact with 
the damaged zone (t =20′). They then rapidly migrated their cell body to surround the 
damaged area. In contrast, microglia away from the injury site stayed in place.
DISCUSSION
In this work we have established a robust protocol that allows the derivation of microglia-
like cells from human pluripotent stem cells. These cells are derived in a defined medium 
that mimics the serum-free environment of the CNS interstitial milieu, supporting 
electrophysiological maturation of neurons, proliferation and maturation of astrocytes, and 
differentiation and maintenance of oligodendrocytes. We demonstrated that pMGLs are 
highly phagocytic and, based on their phenotypic and gene expression profiles, resemble 
primary fetal and adult human microglia. In particular, they bypass a colony-forming 
monocytic stage, are initially amoeboid and capable of proliferation, extensive migration and 
phagocytosis. They eventually settle into a highly ramified morphology, enhanced by co-
culture with differentiated neurons and glia. These cells express many of the markers 
expected to be characteristic of microglial expression phenotypes, such as P2RY12/13, 
HEXB, GPR34 and TMEM119. Transcriptome sequence analysis shows that they resemble 
human primary fetal and adult microglia, unlike other macrophages.
Primary microglia and cell lines have been maintained for short periods on canonical 
polymer linkers such as poly-D-Lysine (PDL) + Laminin, but this is also a substrate for 
neural progenitors, neurons and glia. To exclude the growth of neuro-ectodermal derivatives 
we used Primaria plastic to positively select pMGLs. It is notable that coatings such as PDL 
or matrigel can represent another layer of variability between cultures, and their exclusion 
contributes to the reproducibility of this protocol.
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Macrophage colony stimulating factor (CSF1) is a primary actor of proliferation, 
differentiation and function of myeloid cells, but microglia develop normally in CSF1 
mutant mice, though their numbers are drastically decreased in CSF1R mutant animals 16. 
Therefore, it was suggested that an additional cognate ligand of CSF1R is crucial for 
microglia development. Addition of the recently identified alternative ligand for CSF1R, 
Interleukin-34 (IL-34) to the base medium improved the morphological phenotype of 
microglia-like cells. Immature pMGLs delaminate and adopt directly a macrophage identity, 
with no colony-forming intermediate. This is consistent with our current understanding of 
microglial development, which supports the notion that microglia derive from non-
monocytic primitive myeloid cells acting as precursors, unlike adult bone marrow-derived 
macrophages, but similarly to some other tissue-resident macrophages 37. As pMGLs 
populate the substrate, they clearly isolate from their nearest neighbors, an in vitro behavior 
which may correspond to the ability to tile the CNS by their in vivo counterparts. Unlike 
other tissue-resident macrophages, microglia derive from PU.1+/IRF8+/MYB− 
precursors 34,35. Expression of the same markers in pMGLs supports this ontogeny. pMGLs 
kept in mono-culture express high levels of SELPLG, TXNIP, CST3 and OLFML3, 
suggesting they adopt a relatively more mature profile than primary fetal cells.
Embryonic microglia, when first colonizing the nervous system, do not display the 
extensively ramified morphology observed in the adult CNS, instead adopting an amoeboid 
morphology as they migrate and spread through the parenchyma. Likewise, pMGLs 
progressively adopt a ramified morphology when cultured in isolation, as they lose their 
proliferation potential. In isolation, their morphology and function can be analyzed for cell-
autonomous phenotypes. We showed that MECP2 mutant microglia are smaller than their 
isogenic counterpart: this may contribute to functional differences in Rett microglia worthy 
of further investigation.
pMGLs further adopt canonical high-order branching patterns once embedded in a 
differentiated neuro-glial environment. Their surveying behavior is reminiscent of that 
observed in vivo in the landmark two-photon imaging studies of the dynamic process 
motility of microglia in intact mouse brains 38. Furthermore, they respond to localized injury 
by migrating and encapsulating the damaged area. pMGLs are capable of major and rapid 
morphological changes, as well as secretion of highly bioactive cytokines and chemokines. 
It will be particularly interesting to study their secretomes in the context of disease models 
to which we applied this paradigm.
It is well established that microglia perform key functions in the development of the brain 
such as in circuit refinement, neurogenesis, and neuronal growth 39. Microglia mediated 
inflammation can have deleterious consequences for the brain and much evidence indicates 
that microglial activation contributes to neurodegenerative disease such as AD, PD and 
ALD 40,41. In ALD, phagocytes derived from autologous bone marrow transplants likely 
elicit their beneficial effects by replacing mutant microglia, as they stall terminal neuro-
inflammation and demyelination 42. In addition, other brain dysfunctions including 
depression 43, schizophrenia and autism have been suggested to involve microglial 
dysfunction. The availability of a robust protocol to generate and maintain microglia from 
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patients suffering from these conditions allows studying the interaction of neurons and 
microglia and will facilitate the investigation of these diseases in defined culture conditions.
MATERIALS AND METHODS
Study design
no statistical tests were used to pre-determine sample size. Experimenters were not blinded 
to the genotypes or culture conditions, except for transcriptomic where line genotype was 
not explicit for analysis. 2-tailed Student’s t-tests were performed where appropriate, p<0.05 
was considered significant.
Statement of compliance with IRBs
all experiments involving cells from human donors and animals were performed in 
compliance with established IRB protocols at the Whitehead institute.
Human ES and iPS cell cultures
Human ES cell line WIBR1/2/3 and hES-Rett were previously described 26,44 and cultured 
in 5% O2 on mitomycin C-inactivated mouse embryonic fibroblasts (MEFs) in hESC 
medium, containing DMEM/F12 (Thermo), 15% fetal bovine serum (Hyclone), 5% 
knockout serum replacement (Thermo), 1% non-essential amino acids (Invitrogen), 1mM 
glutamine (Thermo), 0.1mM β-mercaptoethanol (Sigma) and 4ng/ml bFGF (Thermo). 
Cultures were passaged manually or with 1mg/ml collagenase type IV (Thermo) every 5–7 
days. iPS-wt1/2/3, iPS-fAD2, iPS-AMN1/2/3 and iPS-ALD1/2/3/4 were reprogrammed 
from patient fibroblasts using the constitutive excisable STEMCCA lentivirus (OSKM) and 
maintained in the same conditions as WIBR1/2/3. iPS-wt4/5, iPS-fAD1/3 were 
reprogrammed using non-integrative Sendai virus (OSKML), and maintained on inactivated 
mouse embryonic fibroblasts in serum-free hES medium containing DMEM/F12 (Thermo), 
20% knockout serum replacement (Thermo), 1% non-essential amino acids (Thermo), 1mM 
Glutamax (Thermo), 0.1mM β-mercaptoethanol (Sigma) and 12ng/ml bFGF (Thermo). hES-
WIBR3 is a female line, all other lines are male. All parental lines were maintained for over 
50 passages, verified for stable expression of Oct3/4, Nanog and TRA1-60, and routinely 
tested for mycoplasma negativity.
NGD formulation justification
We adjusted the component concentrations to match those of human cerebrospinal fluid, 
providing metabolic substrates necessary for individual cell types growing in the absence of 
others. Ionic concentrations were chosen to match human cerebrospinal fluid osmolality 45, 
thus providing extracellular sodium concentrations necessary for proper electrophysiological 
function. We followed a rationale matched by recent efforts to improve electrophysiological 
activity in iPS derived neurons46. Iron salts were excluded, instead using iron-loaded 
transferrin in Neurobasal, in order to avoid dangerous redox cycling through Fenton 
chemistry. Glutamate was omitted to avoid the excitotoxicity of this amino-acid in 
dissociated cultures 47. We included additional pyruvate48, and lactic acid 49 as energy-
providing and neuroprotective substrates in addition to the more canonical oxidative 
substrates (glucose, galactose and glutamine/Glutamax). Biotin and lipid-loaded albumin 
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(Albumax) were added to support de novo synthesis lipid bilayers (e.g. axons, myelin 
sheaths).
Differentiation to neural progenitors and maintenance
Differentiation of human ES and iPS cells to neural progenitors in 2-D adherent culture was 
performed as follows: 2 million human ES or iPS were passaged onto matrigel-coated dishes 
using PBS w/o Ca2+/Mg2+, filtered through a 40μm mesh to remove mEFS, and cultured 
directly in NGD medium containing dorsomorphin (2.5mM, Stemgent), bFGF (10ng/mL, 
Thermo) and Insulin (additional 10ng/mL) for 3 days until super-confluent. bFGF and 
Insulin were subsequently removed, and NGD + dorsomorphin was replaced every day for 
10 days. Cells were subsequently passaged 1:1 with PBS−/− when rosette lawns were 
observed throughout the culture. Rho-associated protein kinase (ROCK) inhibitor Y27632 
(10mM, Stemgent) was added to the medium during each of the first 3 passages. Initial 
passaging at no more than 1:2 ratio, followed by 1:3 to 1:6 every 5 days. Neural progenitors 
were expanded and maintained in NGD medium with 10ng/ml bFGF, and additional 
10ng/mL Insulin (NGM medium).
Differentiation towards neurons and glia
NPCs were differentiated into neurons and glia by removing FGF and culturing in NGD 
base levels of insulin (5ug/mL) without retinoic acid addition (NGD contains no additional 
retinoid). To initiate differentiation, NPCs were plated in a 35mm dish on 1% matrigel at 
5*105/cm2 and fed 5mL of NGD every 2–3 days. At 4 weeks, neurons appeared in the 
culture and a final dissociation was performed. The culture was dissociated in the presence 
of 0.05% DNase I by incubation with Accutase (Stem Cell Technologies) for 30′ at 37degC 
with gentle agitation (bacterial rotator), re-suspended in chilled HBSS/0.1% BSA and 
filtered through a 40μM mesh before being centrifuged through a cushion of 4% BSA to 
remove cellular debris. For 2D cultures and for medium conditioning, cells were re-plated at 
5*105/cm2 on 0.1% PEI-coated plastic or glass. For re-aggregation with pMGLs, 3D 
cultures were initiated by plating 1.5×106cells in a 0.3cm2 PET transwell with 0.4mm pores 
coated with 0.1% PEI. Cells were mixed with transduced pMGLs in a 1:10 ratio. Spheroid 
formation was initiated by re-aggregating 3*104 NPCs per well in 96-well ultra-low 
attachment plate (corning), mixed with pMGLs at 1:10 ratio.
Differentiation towards pMGLs
Colonies were treated with collagenase IV (1.5mg/mL) and mildly triturated to form a 
suspension of uniform clumps, transferred directly to 5mL MGdM (NGD + 10ng/mL IL-34 
+ 10ng/mL CSF1), in ultra-low attachment 6-well plates (corning). 6 confluent wells 
(~3×106 cells) were pooled into one suspension well. Embryoid bodies were monitored for 
appearance of two main identifiable types. The first group was composed of compact phase-
bright neuralized spheroids, the second group were large, expanding cystic bodies, YS-EBs. 
Every 5 days, EBs were gently triturated to shear off loose cells of interest, settled, and the 
supernatant placed in a single well of a Primaria 6-well plate. Unattached cells and small 
EBs were washed with fresh MGdM. Attached cells were monitored for morphological 
characteristics of microglia/microglial precursors (compact nucleus, vacuoles, membrane 
ruffles, motility), and wells from 6 consecutive productions (one month) were pooled to 
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constitute one synchronized population. Further maintenance was performed in MGM (NGD 
+ 100ng/mL IL-34 + 5ng/mL CSF1). Cells are sensitive to passaging, but can be lifted with 
Accutase, or preferentially with ice-cold PBS with 5ng/mL CSF1. Assays and imaging were 
performed 4–5 days after passaging or feeding. pMGL staining displays cells derived from 
iPS-wt5.
Lentivirus production and transduction
FU-GFP-IRES-PURO-W lentivirus constructs were used for pMGL transduction. VSVG-
coated lentiviruses were generated in HEK293 cells as previously described 50. Sub-
confluent HEK293 cells were transfected using X-tremeGENE 9 (Roche), with a mixture of 
lentiviral construct and second-generation packaging plasmids. Culture medium was 
changed 12 hours after transfection and collected 96 hours later. Virus-containing medium 
was filtered through 0.45μm filter and concentrated by ultracentrifugation (23krpm, 90′, 
4°C). pMGLs cultured in MGdM were transduced at an MOI of 10 (titer assessed by p24 
ELISA). Medium was replaced after 12 hours, and cells were left to recover. Expression was 
evaluated by fluorescence microscopy without additional selection.
EdU click-it assay
EdU (10μM, Life Technologies) was added to MGdM medium for 24 hours, after which 
cells or tissues were fixed using ice-cold methanol. EdU click-it assay was performed on 
fixed cells per the manufacturer’s instruction (Life Technologies), followed by fluorescent 
immuno-staining and imaging. Counting was performed by automated particle counting with 
Fiji. Data is represented as a ratio of EDU positive to DAPI positive nuclei. 6 random fields 
were chosen at 100x magnification, and averaged between two biological replicates to 
generate s.e.m. and t-test values.
Cell size comparison
At least 200 cells were imaged in phase contrast in each of 3 replicate wells of 2 isogenic 
lines of pMGLs (Rett and control). FiJi Gaussian blur was applied to the images, followed 
by background subtraction and thresholding. The particle counting function was used to 
measure average pixel counts (surface) of cell masks, and average perimeters, in each 
replicate. Data is given as mean ± s.e.m., with significance below 0.05 for the t-test.
Imaging
Cells and tissues were fixed with ice-cold methanol or 4% paraformaldehyde in PBS. After 
PFA fixation, permeabilization was effected with PBS containing 0.3% triton. Fixed and 
permeabilized cells were blocked with 3% normal donkey serum. Primary antibodies were 
against TREM2 (Abcam, 1:500), CD11b (Abcam,1:500), TMEM119 (Sigma/Atlas, 1:50), 
P2RY12 (Sigma/Atlas, 1:50), PU.1 (cell signaling, 1:500) and visualized by ad hoc 
secondary antibodies conjugated with Alexa 488, 568, 594, 647 (Life Technologies, 1:1000), 
followed by counter-staining with DAPI. Phase contrast and Fluorescent images of immuno-
staining, as well as time lapse movies, were captured on a wide-field Nikon Ti2000 mounted 
with a SPOT RT monochrome camera. For 3D embedded microglia, observation was 
performed in the culture transwell, placed on a 1.5 coverslip Matek glass-bottom 35mm 
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dish. Optical sectioning through 3D neural cultures was performed on a Zeiss LSM 700 at 
20X magnification. Live imaging and wound assay in 3D culture of cells derived from iPS-
wt5 was performed on Zeiss LSM710, photo-ablation was performed with 2-photon 780nm 
laser at 20% power, acquiring a 25um optical slice at 10X.
Flow Cytometry
Single cell suspensions of pMGLs were blocked with FcR blocking reagent, 1% BSA, to 
avoid non-specific antibody binding, in NGD medium without phenol red. 10^5 cells were 
labeled in 100μL with pre-conjugated rat anti-CD11B-FITC (1:100, StemCells Tech.), 
mouse anti-CD45-AF647 (1:100, Biolegend), and unconjugated rabbit anti-IBA1 (1:100, 
Abcam) followed by AF647 conjugated secondary. Sorting was performed on a customized 
FACS Aria (BD).
Phagocytosis assay
For qualitative assessment of phagocytosis, 1μm polystyrene red-orange fluospheres 
(Thermo) were left to settle at a density of 107/cm2 on PEI coated plastic. pMGLs were 
added the next day at a density of 1000/cm2. Cells were observed after 6 hours, displaying 
their migration on the lawn and the cytoplasmic bead uptake. Alternatively, beads were 
added directly to a pMGL culture medium at a concentration of 108 beads/mL. Phagocytosis 
was observed in real time, highlighting the rapid active uptake.
Primary mouse microglia preparation
All culture conditions were initially tested with mouse primary microglia. C57Bl/6 neonates 
were cold/CO2 anesthetized in a dry ice chamber following approved protocols and whole 
brains were harvested. After meningeal removal, cortical cups were isolated, minced on ice, 
and crudely triturated with a wide-bore fire-polished pipette in a solution of Accutase (Life). 
The preparation was incubated at 37°C with rotation for 10′, followed by further trituration 
with a narrowed pipette. The suspension was further incubated for 10′ at 37°C with DNase I 
0.1%. The final trituration was left to settle for 1 minute, and the supernatant was filtered 
through a 70μm mesh, and spun through a 4% BSA cushion to remove cell debris. This 
preparation was plated directly on matrigel coated plate, and grown in complete Neurobasal 
with 5% serum. After a week, loosely adherent microglia were harvested and further used on 
different surfaces. Alternatively, MACS sorting (Miltenyi) for CD11b was applied to the 
cortical suspension, following the manufacturer’s instructions. Flow-through was discarded 
while retained cells were eluted directly onto test surfaces and used accordingly.
Primary fetal human microglia
Cells were obtained from first trimester aborted fetuses from ScienCell (#1900), and 
cultured on Primaria in MGdM and MGM. ScienCell strictly adheres to the guidelines for 
human tissue collection and distribution according to established protocols. Human tissue 
used for the isolation of primary cells is derived from donors who have signed informed 
consent by the donor themselves or an authorized agent acting on the donor’s behalf.
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RNA extraction, reverse transcription and quantitative PCR
Cells and tissues were homogenized and total RNA extracted using the RNeasy Micro kit 
(Qiagen) following the manufacturer’s instructions. Total RNA concentrations were 
measured using NanoDrop ND-1000 spectrophotometer. For RNAseq, RNA was directly 
analyzed and quality checked before sequencing. RNA was reverse transcribed into cDNA 
using Superscript III reverse transcriptase (Invitrogen) with random hexamer primers. 
Transcript abundance was determined by quantitative PCR using SYBR Green PCR mix 
(Applied Biosystems), with primer pairs against IL6, TNFα and GAPDH.
RNAseq and Analysis
Samples were prepared using the SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing 
(Clontech), according to manufacturer’s protocols and using 10 ng of input. Final libraries 
were evaluated for size using a Fragment Analyzer (Advanced Analytical Technologies) and 
quantified using both Qubit (Thermo Fisher) and qPCR (Roche LightCycler 480, KAPA 
Illumina Library Quantification Kit) before sequencing. RNA-seq 75 bp paired-end reads 
from Illumina were checked with FastQC and fastq_screen. Reads were mapped to human 
genome hg19 using TopHat v 2.0.13 with Ensembl annotation (GRCh37.75) in gtf format. 
FeatureCounts was used to obtain gene counts with default option. The gene counts were 
normalized with DESeq, and PCA plot was created with plotPCA function. Bar charts 
represent the average normalized raw reads for different PSC lines and primary samples. 
Gene ontology differently selected top features for FMG, pMGLs and differentiated NPCs, 
ran on the online Gene Ontology Consortium tool (geneontology.org). Hierarchical 
clustering was performed on quantile normalized FPKMs from the different GEO datasets. 
For HMDM and iPSDM, we used GSE55536. For the comparison to adult human microglia, 
and other brain cells, we used GSE73721. Biological replicates of pMGLs, FMGs and 
differentiated NPCs were used for analyses. The values for pMGL3 were the average of two 
technical replicates.
Gene ontology
For supplementary table 3, average expression values for fMGs and pMGLs were ranked, 
the gene list associated with the top 300 values in each set was submitted to the panther 
algorithm at geneontology.org. For Suppl. Table 4–7, the ratios of expression were ranked, 
and the gene lists corresponding to the top 200 values were submitted.
Cytokine profiler
2mL of NGD was added to 100k pMGLs in a 35mm well and allowed to condition for 24 
hours. For IFN-γ/LPS stimulation, LPS was added at 100ng/mL along with 20ng/mL IFN-γ 
at the onset. 400uL of this supernatant were added to a prepared cytokine antibody panel 
membrane, per the manufacturer’s instructions (RnD Systems, kits ARY005 and 
replacement ARY005B). After incubation, the membranes were revealed with ECL reagent.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. induction of primitive myelogenesis from human pluripotent stem cells
(a) top panel: example image depicting the typical formation of cystic EBs bound by a 
single cell layer. lower panel: example of neuralized spheroid EB structures. Scale bars: 
200μm. (b) typical appearance of endothelial lawns emerging from plated cystic EBs (on 
PDL coated plastic). Phase panels display the island formations with raised edges (left), and 
the progressive merger of such edges into raised ropes. Subsequent panels depict staining for 
VE-Cadherin (green), and c-kit (magenta). Scale Bars: 80μm. (c) higher magnification of 
raised structures surrounding islands (phase), staining for CD41 (green), and CD235a 
(magenta). Scale bar: 25μm. (d) after 2 weeks in suspension culture, cystic EBs can be 
plated to PDL coated plastic (left, phase contrast. Scale bar: 200μm), and large domains 
stain positive for the nucleus-localized transcription factor PU.1 (right, green). (e) 
Delamination of grape-like structures towards the luminal side from YS-EBs (red 
arrowheads, top left and right, scale bars:40 μm and 25μm, respectively). Putative myeloid 
cells are seen delaminating outward into the suspension medium (red arrowhead, bottom 
left, scale bar: 25μm). Homogeneous population of round motile cells seen delaminating and 
spreading away from the source YS-EB (Bottom right, scale bar: 80μm).
Muffat et al. Page 18
Nat Med. Author manuscript; available in PMC 2017 March 26.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. characterization of phagocytes delaminating from cystic YS-EBs
(a) differentiation protocol schematic showing the suspension culture (top row), and the 
selective adherent conditions (bottom row). (b) low magnification view of delaminated lawn 
after plating stained for nuclear DAPI (grey scale), nuclear PU.1 (magenta) and membrane 
CD11b/ITGAM (green pseudocolor). Merged PU.1 and CD11b channels are depicted in the 
right panel. Scale bar: 25μm. (c) high magnification view of ramified cell in resting culture 
viewed under phase contrast (grey scale) and stained for nuclear PU.1 (magenta) and 
cytoplasmic IBA1/AIF1. Merged PU.1 and IBA1 channels are depicted in the right panel. 
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Scale bar: 5μm (d, e) FACS scatter plots of harvested pMGLs for CD11b and IBA1 (left) or 
CD45 (right). (f) left panel, example image depicting the migratory path (white dashed 
arrow) of a single pMGL on a fluorescent bead lawn (yellow), as well as intracellular 
accumulation of phagocytosed fluorescent beads (arrow head) Scale bar: 10μm. Right panel, 
example image depicting a cotton fiber opsonized by pMGLs (scale bar: 25μm). (g) 
extracted frames from supplementary movie 2 depicting fluorescent beads (red arrowheads) 
taken up by a single pMGL Scale bar: 3μm. h: Quantification of pMGL EdU incorporation, 
measured at 2 weeks and 2 months (mean ± s.e.m. of 2 biological replicates, t-test, P<0.05).
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Figure 3. pMGLs adopt ramified morphologies over time and express specific markers of 
microglia
(a) example phase contrast images of depicting morphologies of human fetal microglia 
(hFMG; left) and pMGLs derived from human ES cells (hES pMGLs, middle) or induced 
pluripotent stem cells (iPS pMGLs, right). Scale bars: 25μm. (b) example high 
magnification images depicting morphologies of mouse primary neonatal microglia 
(mNMG, left), hFMG (middle) and hiPS pMGLs (right). scale bars: 10μm. (c) Example of 
phenotypic output in freshly plated MECP2 mutant (right panel) and isogenic wild-type cells 
(left panel, scale bar: 25μm). Average cell spread (surface) and perimeter are significantly 
lower in MECP2 mutant microglia (mean ± s.e.m. for 2 biological replicates, TTEST, 
p<0.05). (e–f) example images of ramified pMGLs (phase) stained for DAPI (magenta) and 
either TMEM119 (e, green) or P2RY12 (f, green). Scale bars: 10μm (g) Example confocal 
image representing an optical slice of wider field-of-view, stained for IBA1 (red), 
TMEM119 (green) and CD45 (white). Scale bar: 20μm.
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Figure 4. pMGLs cytokine profiles in response to endotoxin challenge
(a) Baseline cytokine profiler assay from 105 pMGLs conditioning 2mL of NGD in 24 
hours. Top panel: 10′ exposure, showing baseline secretion of detectable CCL2, MIP1α/β, 
CXCL1 and IL8. Lower Panel: profile after stimulation for 24hours with 100ng/mL LPS and 
20ng/mL IFN-γ. IL6, TNFα, MIP1α/β and CXCL10 display a dramatic increase. (b) map, 
to scale, of the spots blotted in panel a. Green highlights cytokines showing a significant 
upregulation. (c, d) Quantitative qPCR of TNFα (c) and IL6 (d) transcription in pMGLs at 
baseline (−) and after LPS stimulation (+). Data are presented as mean ± s.e.m. from 2 
biological replicates, t-test significance is reported.
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Figure 5. pMGLs recapitulate the consensus signature distinguishing primary microglia from 
other macrophages
(a) Quantification of normalized expression (counts from RNAseq data) of the indicated 
genes for pMGLs (black bars, N=5), primary human fetal microglia (red bars, hFMG, N=2), 
and differentiated human neural progenitors (red bars, Diff. NPCs, N=4). Data are presented 
as mean ± s.e.m. (b) Dendrogram depicting the results of unbiased hierarchical clustering of 
fMGs (N=2), pMGLs (N=5) and NPCs (N=4) derived in this study, compared to a published 
dataset (GSE73721) 31 for adult primary microglia (N=3), fetal astrocytes (N=6), mature 
astrocytes (N=12), neurons (N=1) and whole cortex (N=4), using genes in Suppl. Table 8.
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Figure 6. neural co-cultures enhance the microglial signature of pMGLs
(a) top: schematic representation of transwell culture system exposing pMGLs to 
conditioned medium from differentiating neuro-glial cultures. Bottom: schematic 
representation of direct re-aggregation after GFP transduction, as free-floating spheroids or 
3D stacks in transwells. (b) Principal component analysis comparing RNAseq profiles from 
differentiated neural cultures (full squares, NPC1 in red, NPC2 in blue, NPC3 in green) to 
those of primary fetal microglia (fMG1 and fMG2, open triangles. fMG1+ NCM, closed 
triangle), and pMGLs (circles, pMGL1 in red, pMGL2 in blue, and pMGL3 in green) in the 
absence (open circles) or presence (full circles) of neural progenitor conditioned medium 
(+NCM). N=1 for each sequencing data point. (c) phase contrast (left) and fluorescence 
(right) images depicting the relative tiling position of GFP-labeled pMGLs in 3d culture on 
transwell. Scale bar: 200 μm. (d) representative image of a GFP-positive pMGL (grey scale) 
after 4 weeks in 3D neural stacks (live observation). Scale bar: 10μm. (e): Optical section 
through a fixed 3D neuroglial culture (without embedded pMGLs), stained for DAPI (blue, 
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top), neuronal MAP2 (green, middle) and astrocytic GFAP (magenta, bottom). Scale bar: 
50μm. (f) Maximum projection of supplementary movie 5 (scale bar: 2μm) pointing to 
rapidly extending (yellow arrowhead) and retracting (red arrowhead) protrusions in the 3D 
neuroglial cultures. (g) 1/5 frames of supplementary movies S5 and S6, showing branch 
movements over 300s. (h) Example montage of time-lapse images depicting GFP-labeled 
pMGLs (grayscale) response to localized cellular damage in 3D culture. Yellow arrowhead 
indicates the site of two-photon laser ablation after 5 minutes of acquisition. Red arrowheads 
point to microglia-like cells further away from injury, not reacting to the damage. Bottom 
right panel represent the color-coded individual trajectories of pMGLs during acquisition, 
highlighting radial migration towards the injury. Scale bar = 100μm.
Muffat et al. Page 25
Nat Med. Author manuscript; available in PMC 2017 March 26.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
